VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BDTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BDTXBlack Diamond Therapeutics, Inc.
$2.08$119M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBDTXQuarterly Financials

Black Diamond Therapeutics, Inc. (BDTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Black Diamond Therapeutics, Inc. (BDTX) quarterly income statement — complete revenue, gross profit & net income history

BDTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000070M000000000000000
Revenue Growth %-100%-------------------
Cost of Goods Sold27K0086K00086K86K00000000000
COGS % of Revenue--------------------
Gross Profit-27K00-86K70M00-86K-86K00000000000
Gross Margin %----100%---------------
Gross Profit Growth %-100.04%--0%81495.35%---------------
Operating Expenses11.26M17.61M10.98M13.33M15.47M18.27M18.13M22.04M20.16M20.86M24.01M20.03M21.56M21.85M22.12M23.17M25.68M26.08M35.36M34.72M
OpEx % of Revenue----22.1%---------------
Selling, General & Admin4.26M3.97M3.54M4.1M4.96M5.98M5.22M9.57M6.7M5.57M7.86M6.88M6.81M7.24M6.28M6.98M7.89M6.42M7.74M8M
SG&A % of Revenue----7.09%---------------
Research & Development7M6.3M7.44M9.32M10.51M12.3M12.91M12.47M13.46M15.29M16.15M13.15M14.75M14.61M15.85M16.2M17.79M19.66M27.63M26.72M
R&D % of Revenue----15.01%---------------
Other Operating Expenses01000K0-86K0000000000000000
Operating Income-11.26M-17.61M-10.98M-13.42M54.53M-18.27M-18.13M-22.13M-20.25M-20.86M-24.01M-20.03M-21.56M-21.85M-22.12M-23.17M-25.68M-26.08M-35.36M-34.72M
Operating Margin %----77.9%---------------
Operating Income Growth %-120.65%3.64%39.45%39.36%369.34%12.37%24.5%-10.47%6.1%4.56%-8.53%13.55%16.04%16.21%37.44%33.25%16.39%-12.5%-91.36%-131%
EBITDA-11.23M-17.54M-10.89M-13.33M54.62M-18.19M-18.04M-22.04M-20.16M-20.77M-23.9M-19.92M-21.44M-21.73M-22M-23.05M-25.55M-25.96M-35.32M-34.7M
EBITDA Margin %----78.02%---------------
EBITDA Growth %-120.57%3.55%39.64%39.51%370.92%12.42%24.49%-10.67%5.97%4.4%-8.65%13.57%16.1%16.3%37.73%33.58%16.75%-12.04%-91.28%-131.07%
D&A (Non-Cash Add-back)27K66K86K86K87K85K86K86K86K86K115K114K122K126K129K128K125K123K43K20K
EBIT-11.26M-10.26M-8.5M-10.56M54.53M-18.27M-18.13M-22.13M-20.25M-20.86M-24.01M-20.03M-21.56M-21.85M-22.12M-23.17M-25.68M-25.87M-35.36M-34.72M
Net Interest Income1.02M1.18M1.16M1.12M595K565K516K464K637K324K439K539K622K677K562K386K406K588K776K948K
Interest Income1.02M1.18M1.16M1.12M595K565K516K464K637K324K439K539K622K677K562K386K406K588K776K948K
Interest Expense00000000000000000000
Other Income/Expense2.22M2.49M2.48M2.86M2.01M2.29M2.57M2.22M2.02M1.45M1M880K686K774K470K243K172K213K287K364K
Pretax Income-9.04M-15.12M-8.5M-10.56M56.54M-15.98M-15.56M-19.91M-18.23M-19.41M-23.01M-19.15M-20.88M-21.08M-21.65M-22.93M-25.51M-25.87M-35.08M-34.35M
Pretax Margin %----80.77%---------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-9.04M-15.12M-8.5M-10.56M56.54M-15.98M-15.56M-19.91M-18.23M-19.41M-23.01M-19.15M-20.88M-21.08M-21.65M-22.93M-25.51M-25.87M-35.08M-34.35M
Net Margin %----80.77%---------------
Net Income Growth %-115.98%5.44%45.38%46.95%410.24%17.64%32.38%-3.95%12.69%7.92%-6.25%16.48%18.16%18.51%38.27%33.25%15.82%-14.32%-95.83%-135.75%
Net Income (Continuing)-9.04M-15.12M-8.5M-10.56M56.54M-15.98M-15.56M-19.91M-18.23M-19.41M-23.01M-19.15M-20.88M-21.08M-21.65M-22.93M-25.51M-25.87M-35.08M-34.35M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.16-0.26-0.15-0.190.98-0.28-0.28-0.36-0.35-0.41-0.45-0.52-0.57-0.59-0.60-0.63-0.70-0.71-0.97-0.95
EPS Growth %-116.33%7.14%46.43%47.22%380%31.71%37.78%30.77%38.6%30.51%25%17.46%18.57%16.9%38.14%33.68%16.67%-12.7%-94%-131.71%
EPS (Basic)-0.16-0.26-0.15-0.191.00-0.28-0.28-0.36-0.35-0.41-0.45-0.52-0.57-0.59-0.60-0.63-0.70-0.71-0.97-0.95
Diluted Shares Outstanding57.23M57.09M56.93M56.8M57.67M56.61M56.51M55.16M51.81M47.45M50.94M36.52M36.48M36.39M36.35M36.29M36.27M36.23M36.22M36.18M
Basic Shares Outstanding57.23M57.09M56.65M56.8M56.66M56.61M56.51M55.16M51.81M47.45M50.94M36.52M36.48M36.39M36.35M36.29M36.27M36.23M36.22M36.18M
Dividend Payout Ratio--------------------